Similarly, oral Wegovy at the 25 mg dose achieved around 13% weight loss over a comparable time frame
In addition, this is also promoting efforts to better comprehend the implication of the association between metabolism and NBD on the use of both traditional and emerging drugs generally used for T2DM and MetS to also treat conditions that up to now were only therapeutically approached from a neurologists perspective
Prescriptions are only provided if clinically appropriate after a medical evaluation
This dual benefit on glycaemic control and weight management has made them increasingly popular therapeutic options
A medication like semaglutide is a powerful tool, but it works best when it is part of a larger, sustainable lifestyle change
A specific pathway for managing frailty has been introduced, which advises us to exercise caution when prescribing SGLT2 inhibitors in those with moderate to severe frailty in whom safety is a concern, reflecting the importance of balancing benefit and risk in vulnerable populations
